Krystal Biotech, Inc. KRYS Total Revenue
Total Revenue at other companies
Segments
By geography
See fullOther financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s total revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s total revenue?
- Krystal Biotech, Inc. (KRYS) reported total revenue of $116.36M in Q1 2026.
- How has Krystal Biotech, Inc.'s total revenue changed year-over-year?
- Krystal Biotech, Inc.'s total revenue increased by 31.9% year-over-year, from $88.18M to $116.36M.
- What does total revenue mean?
- The total amount of money brought in from sales before any expenses are deducted.
- How do you interpret total revenue?
- An increase indicates growing market share or successful product adoption, while a decrease may signal market saturation or competitive pressure.
- How does total revenue compare across companies?
- Standard across all industries; peers in biotech typically show high growth during commercial launch phases.